Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Neuromodulation Devices Market Report Overview
The neuromodulation devices market size was valued at $6.06 billion in 2023. Factors such as deep brain stimulation and spinal cord stimulation will drive the market growth at a CAGR of more than 6% from 2023 to 2033. Neuromodulation is one of the fastest-growing medical device markets. Within the last 10 years, the market has grown exponentially, with spinal cord stimulation being the largest market.
Neuromodulation Devices Market Outlook 2023-2033 ($ Billion)
Buy Full Report for More Insights on the Neuromodulation Devices Market Forecast, Download a Free Sample Report
Neuromodulation devices market research report identifies quantitative market trends within drug delivery devices therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the neuromodulation devices market for 2020 and beyond. Furthermore, the report provides neuromodulation devices market share by the company to help in identifying untapped market opportunities.
Market Size (2023) | $6.06 billion |
CAGR (2023-2033) | >6% |
Historic Period | 2015-2022 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Neuromodulation Devices Market Segments
The key segments in the neuromodulation devices market are Deep Brain Simulators (DBS), Gastric Electric Simulators (GES), Peripheral Nerve Simulators (PNS), Sacral Nerve Simulators (SNS), Spinal Cord Stimulators (SCS), and Vagus Nerve Stimulators (VNS). In 2023, the SCS segment dominated the market share due to its greater success rate in comparison to other segments. Non-Rechargeable Spinal Cord Stimulators (SCS) and Rechargeable Spinal Cord Stimulators (SCS) are the sub-categories of the neuromodulation devices market.
A VNS is a device of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. VNSs help to treat neurological disorders like epilepsy and depression.
Neuromodulation Devices Market Analysis by Segments, 2023 (%)
Buy Full Report for More Insights on the Neuromodulation Devices Market Segments, Download a Free Sample Report
Regional Analysis of Neuromodulation Devices Market
The key regions in the Neuromodulation devices market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America was the leading regional market.
North America will continue to retain its position during the forecast period. Furthermore, the US is the largest revenue contributor to the regional market. The market will also grow rapidly during the forecast period due to the rising patient adoption rates of SCS and PNS.
Neuromodulation Devices Market Analysis by Regions, 2023 (%)
Buy Full Report for More Insights on the Neuromodulation Devices Market Regions, Download a Free Sample Report
Neuromodulation Devices Market – Competitive Landscape
In 2023, Medtronic Plc’s neuromodulation devices market share was the highest
The major players in the neuromodulation devices market are:
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corp
- LivaNova Plc
- Nevro Corp
Neuromodulation is a market that has immense potential but the lack of patients traditionally hampers the adoption. Cultural differences regarding treatment risk must come under consideration while marketing each national market.
Neuromodulation Devices Market Analysis by Companies, 2023 (%)
Buy Full Report for More Insights on the Companies in the Neuromodulation Devices Market, Download a Free Sample Report
Neuromodulation Devices Market Dynamics
Trends: The key factors positively impacting the neuromodulation devices market are deep brain stimulation and spinal cord stimulation. The neuromodulation market will expect to grow further through the expansion of therapeutic areas. Functional Neuromodulation is a venture company that focuses on deep brain stimulation for early-onset Alzheimer’s.
Future Outlook: The device records the neurological activity of a diseased patient and through a closed electrical system. This will allow for patients to live an ordinary life with the implanted device. Saluda Medical from Australia is the main company to drive this market driver. This company has shown success in developing a closed-loop DBS and SCS device.
Segments Covered in this Report.
Neuromodulation Devices Segment Outlook ($ Million, 2015-2033)
- Deep Brain Stimulators (DBS)
- Gastric Electric Stimulators (GES)
- Leads
- Peripheral Nerve Stimulators (PNS)
- Sacral Nerve Stimulators (SNS)
- Spinal Cord Stimulators (SCS)
- Vagus Nerve Stimulators (VNS)
Neuromodulation Devices Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
- The neuromodulation devices market research report includes an insightful review of the key industry trends.
- The neuromodulation devices market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, Country, and Global Neuromodulation Devices Market Insights:
- The neuromodulation devices market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Neuromodulation devices market SWOT analysis.
- The report provides trends and neuromodulation devices market competitive dynamics.
Buy the Full Report for More Insights on the Neuromodulation Devices Market Share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies covered- Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, LivaNova Plc, Nevro Corp, SunMed Holdings LLC, Beijing Pins Medical Co Ltd, Curonix LLC, Laborie Medical Technologies Inc, Bioness Inc, Avanos Medical Inc, IntraPace Inc, B. Braun Melsungen AG, Axonics Inc, NeuroPace Inc, Xavant Technology (Pty) Ltd, ReShape Lifesciences Inc and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the neuromodulation devices market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the neuromodulation devices market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on the neuromodulation devices market.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the neuromodulation devices market.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of neuromodulation devices market share by company. Identify strong competitors and create winning strategies to stand out in the global infusion pumps market.
- Track regional neuromodulation devices market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global neuromodulation devices market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Abbott Laboratories
Boston Scientific Corp
LivaNova Plc
Nevro Corp
SunMed Holdings LLC
Beijing Pins Medical Co Ltd
Curonix Inc
Laborie Medical Technologies Inc
Bioness Inc
Avanos Medical Inc
IntraPace Inc
B. Braun Melsungen AG
Axonics Inc
NeuroPace Inc
Xavant Technology (Pty) Ltd
ReShape Lifesciences Inc
Others
Frequently asked questions
-
What was the neuromodulation devices market size in 2023?
The neuromodulation devices market size was $6.06 billion in 2023.
-
Which was the leading segment in the neuromodulation devices market in 2023?
Spinal Cord Stimulators (SCS) segment was leading the neuromodulation devices market in 2023.
-
Which region held the largest share of the neuromodulation devices market in 2023?
North America was the largest regional market for neuromodulation devices in 2023.
-
Which are the leading companies in the neuromodulation devices market?
The leading companies in the neuromodulation devices market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, LivaNova Plc, Nevro Corp, and SunMed Holdings LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.